An ultrasensitive green synchronous factorized spectrofluorimetric approach for the simultaneous determination of Favipiravir and Molnupiravir: Application to pharmaceutical, environmental, and biological matrices
- 7 August 2024
- journal article
- research article
- Published by Wiley in Luminescence
- Vol. 39 (8) , e4837
Abstract
During the pandemic, Favipiravir (FVP) and Molnupiravir (MPV) have been widely used for COVID‐19 treatment, leading to their presence in the environment. A green synchronous spectrofluorimetric method was developed to simultaneously detect them in environmental water, human plasma, and binary mixtures. Maximum fluorescence intensity was achieved at pH 8, with MPV exhibiting two peaks at 300 and 430 nm, and FVP showing one peak at 430 nm. A fluorescence subtraction method effectively removed interference, enabling direct determination of MPV at 300 nm and FVP at 430 nm. The method showed linearity within 2–13 ng/mL for FVP and 50–600 ng/mL for MPV, with recoveries of 100.35% and 100.12%, respectively. Limits of detection and quantification were 0.19 and 0.57 ng/mL for FVP and 10.52 and 31.88 ng/mL for MPV. Validation according to ICH and FDA guidelines yielded acceptable results. The method demonstrated good recoveries of FVP and MPV in pharmaceuticals, tap water and Nile water (99.62% ± 0.96% and 99.69% ± 0.64%) as per ICH guidelines and spiked human plasma (94.87% ± 2.111% and 94.79% ± 1.605%) following FDA guidelines, respectively. Its environmental friendliness was assessed using Green Analytical Procedure Index (GAPI) and the Analytical Greenness Metric (AGREE) tools.Keywords
This publication has 51 references indexed in Scilit:
- Therapeutics for COVID-192023
- Zinc(II) complexation strategy for ultra‐sensitive fluorimetric estimation of molnupiravir: Applications and greenness evaluationArchiv der Pharmazie, 2023
- Presence and toxicity of drugs used to treat SARS-CoV-2 in Llobregat River, Catalonia, SpainEnvironmental Science and Pollution Research, 2023
- Insights on the Quantitative Concurrent Fluorescence-Based Analysis of Anti-COVID-19 Drugs Remdesivir and FavipiravirJournal of Fluorescence, 2022
- Highly sensitive high‐performance thin‐layer chromatography method for the simultaneous determination of molnupiravir, favipiravir, and ritonavir in pure forms and pharmaceutical formulationsJournal of Separation Science, 2022
- Quantitative analysis of favipiravir and hydroxychloroquine as FDA‐approved drugs for treatment of COVID‐19 using synchronous spectrofluorimetry: application to pharmaceutical formulations and biological fluidsLuminescence, 2022
- COVID-19 drugs in aquatic systems: a reviewEnvironmental Chemistry Letters, 2022
- Drug repurposing approach to fight COVID-19Pharmacological Reports, 2020
- Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical TrialsCPT: Pharmacometrics & Systems Pharmacology, 2020
- FLUORESCENCE IMMUNOASSAYS1996